No Detail Found!

One-week triple therapy for eradication of Helicobacter pylori

Author(s)
Najmul Hassan Shah Department of Gastroenterology, Postgraduate Institute, Hayatabad Medical Complex, Peshawar and Khyber Teaching Hospital, Peshawar, Pakistan.
Muhammad Sadiq Shah Department of Gastroenterology, Postgraduate Institute, Hayatabad Medical Complex, Peshawar and Khyber Teaching Hospital, Peshawar, Pakistan.
Ikramullah Khan Department of Gastroenterology, Postgraduate Institute, Hayatabad Medical Complex, Peshawar and Khyber Teaching Hospital, Peshawar, Pakistan.
Khalid Hameed Department of Gastroenterology, Postgraduate Institute, Hayatabad Medical Complex, Peshawar and Khyber Teaching Hospital, Peshawar, Pakistan.
Abstract
The optimum therapy for Helicobacter pylori infection is yet to be defined in Pakistan despite a high prevalence of helicobacter associated diseases in this community. The most popular and effective regimen was, therefore, chosen among the currently recommended combinations used worldwide to document its efficacy in our symptomatic Helicobacter positive dyspeptic patients. Design : It was a prospective, non-randomized study. Place and Duration of Study: The study lasted from January 1998 till June 1999 at the Postgraduate Institute, Government Lady Reading Hospital and Fauji Foundation Hospital, Peshawar. Subjects and Methods: Consecutive dyspeptic patients with peptic ulcer disease as well as non ulcer dyspepsia, with a positive H. pylori status on histology from the specimens obtained from the antral region of the stomach, who consented to take part in the study were enrolled. They were given omeprazole 20 mg bd, clarithromycin 500 mg bd. and amoxycillin 1 gm bd for one week. One group comprised patients with confirmed peptic ulcer disease while the second group comprised patients with macroscopic/microscopic antral gastritis. Patients with peptic ulcer disease were given additional course of omeprazole for another 4 weeks to ensure healing of their ulcers. All patients were re scoped after stopping all drugs and their H. pylori status re-assessed on histology. Results: A total of 84 patients consented to enter the study. Fifty-nine were males and 25 females. Fifty-eight patients completed the study while others were lost to follow-up. There were no dropouts due to side effects of the drugs. Sixteen patients had peptic ulcer disease while 68 had macroscopic/microscopic active antral gastritis only. The Helicobacter pylori eradication has been successful in only 12 patients giving a cure rate of 20.60% as determined per protocol analysis. The eradication rates were disappointingly low in both groups. Conclusion: The results are extremely disappointing, raising concerns of possible antibiotic resistance and highlights the need for setting up trials for two weeks regimen and even considering culture sensitivity patterns for this important human pathogen on priority basis in our community
Publication Details
Page(s) 143-145
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 12, Issue: 3, Year: 2002

Request the full text from PASTIC

Keywords
Helicobacter pylori Histology. Peptic ulcer. Gastritis.
References
Shah N,Shah MS,Khan I,Hameed K. .1999 .An audit of diagnostic upper G! endoscopy: a comparisonof booked versus open excess. J Coll Physi Surg Pakistan, 9 : 174-6.
Van derHulst RW .1996 .TytgatGNJ. Helicobacter pylori and peptic ulcerdisease. Scand J Gastroenterol, 31(suppl) : 10-18.
Consensus NIH .1994 .Helicobacter pylori in peptic ulcerdisease. SAMA, 272 : 65-9.
Van derHulst RW,Van derEnde A,Dekker FW,Ten KateFJ,Weel JF .1997 .KellerJJ. EffectofHelicobacter pylori eradication on gastritis in relationto cag A : a prospectiveone year follow-usptudy. Gastroenterology, 113 : 25-30.
Kazmi SU,Shahid M .1996 .ManzoorH, QuraishyS. A five yearsstudy ofthe prevalenceof Helicobacter pylori infection in Karachi, Pakistan. S Coll Physi Surg Pakistan, 6 : 39-42.
.1992 .Helicobacter pylori resultsofa multicentresurveyin 1991 ofthe metronidazoleresistance in Helicobacter pylori. EurJCiin Microbioio infec Dis, 11 : 777-81.
Genta RM,Klein RD .1993 .etai. Clarithromycians monotherapyfor eradication of Helicobacter pylori: a randomized doubleblindtrialA. m JGastroenterol, 88 : 1860-4.
Van derHulst RWM,Keller JJ,Rauws EA,Pipkin GA,Dixon JS .1996 .dual therapy regimens foreradication ofHelicobacter pylori: a review. Helicobacter1997;, 2 : 159-71.
Laine L,Trujillo K,Sheikh R .1996 .of the Helicobacter pylori associated peptic ulcer. JCollPhysiSurg Pakistan, 6 : 196-8.
Bazzoli F,etai Efficacyand ZagariRM .1993 .­r abilityofa short-terml,ow-dosetripletherapyforthe eradicationofHelicobacter pylori. Gastroenterology, 104 : A140.
Lal S,Sheikh MR . .Lowdose, short-termtriple therapyforHelicobacter pylori associated peptic ulcer. , 47 : 228-30.
Moayyedi P,Axon ATR,Uygun A,Kilinc R,Dagalp K. .1999 .35:A62. nation on Helicobacter pylori in a Turkishpopulation. AmJGastroenterol, 94 : 3073-4.
Elamine I,Goldfain D,ni L,Pamuk ON,Pamuk GE,Celik A,Uzunismail H. .1995 .Results froma randomised study involving 120 patients. Gastroenterology, 108 : A81-40.
. .Evaluationof Helicobacter pylori antibiotic resistance in Portugal. , : .
Wong BOY Chang FY,Abid S .1995 .new standards forHelicobacter pylori treatment. Tripletherapywith EurJ GastroenterolHepatol, 7(suppl 1) : 1-3.
Lind T,Unge P .2000 .The eradicationofHelicobacter pylori in duodenalulcer MACH 1 study: optimal one-week treatment for patients in Asia and Africa Aliment Pharmacol Ther Helicobacter pylori defined. Gut, 14 : 1592-35.
0

Citations

0

Downloads

56

Views